Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06000553 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas

Name: Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas — clinical trial record (NCT06000553)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot applicable

SponsorInstitut Paoli-Calmettes

StartedOct 30, 2023

View on ClinicalTrials.gov ↗

Record History

Minor Aug 17, 2023 Study First Submitted

Institut Paoli-Calmettes

78 trials monitored

See 1 trial at risk

This trial is a prospective, exploratory and descriptive study. The primary objective is to identify early diagnostic biomarkers in patients with TIPMP based on the analysis of Treg lymphocyte subpopulations and epigenetic signatures, and the secondary objective is to characterize the biological processes underlying the transformation of a pre-neoplastic lesion into established ADPC.

Trial Details

NCT Number	NCT06000553
Lead Sponsor	Institut Paoli-Calmettes
Conditions (from sponsor)	PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
Enrollment	360 participants
Start Date	Oct 30, 2023
Primary Completion	Oct 30, 2028 (estimated)
Study Completion	Oct 30, 2028 (estimated)
Updated on ClinicalTrials.gov	Aug 21, 2023